Showing results (161-170 of 335) with videos related to

Sort By:
Pageof 34
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|June 7, 2016
[Clinical Efficacy of Second-generation Tyrosine Kinase Inhibitor in Treating Chronic Myeloid Leukemia]Su-juan Lyu, Huan-ling Zhu, Xiang-long Li, et al.
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|October 8, 2014
[Efficacy of tyrosine kinase inhibitor in treatment of chronic myeloid leukemia patients]Xiang-Long Li, Huan-Ling Zhu, Hong-Ying Liu, et al.
Journal of Biomedical Nanotechnology|June 15, 2019
Anti-Tumor Study of H6, a 4-Substituted Coumarins Derivative, Loaded Biodegradable Self-Assembly Nano-Micelles In Vitro and In VivoZejiang Zhu, Zhengying Su, Jianhong Yang, et al.
Frontiers in Pharmacology|January 30, 2023
Treatment attrition rates and relevant risk factors in multiple myeloma: A real-world study in ChinaWenjiao Tang, Jinrong Yang, Yan Li, et al.
Biomaterials Science|September 2, 2024
Polymeric nanoformulations aimed at cancer metabolism reprogramming with high specificity to inhibit tumor growthYu Xia, Ming-Kang Zhang, Jing-Jie Ye, et al.
BMC Microbiology|July 12, 2026
Blood mNGS: an effective non-invasive diagnostic tool for Pneumocystis jirovecii pneumoniaYuhui Chen, Sifen Lu, Ailin Zhao, et al.
Journal of Thrombosis and Haemostasis : JTH|September 1, 2020
First-in-patient study of hetrombopag in patients with chronic idiopathic thrombocytopenic purpuraZhenlei Wang, Li Chen, Fengkui Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 29, 2019
Leukemic IL-17RB signaling regulates leukemic survival and chemoresistanceHe-Zhou Guo, Li-Ting Niu, Wan-Ting Qiang, et al.
Pageof 34